MYND · Insider Trading

Mynd.ai, Inc. American Depositary Shares, each representing ten (10) Class A Ordinary Shares

Every open-market purchase and sale reported by MYND officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
21
most recent
Open-Market Buys
0
code P
Sales
0
code S
Reporting Insiders
9
current holders
MYND — Recent Form 4 Transactions (latest 2026-10-13)
FiledInsiderRole TypeSharesValue
2026-10-13 Allyson G. Krause General Counsel F −20,769 −$6.02K
2026-10-13 Arthur G. Giterman CEO and CFO F −65,407 −$18.97K
2026-10-13 Lance I. Solomon Chief Product Officer F −10,670 −$3.09K
2026-10-13 Michael B. Strand Chief Revenue Officer F −4,216 −$1.22K
2026-07-14 Arthur G. Giterman CEO and CFO F −65,407 −$26.82K
2026-07-14 Michael B. Strand Chief Revenue Officer F −4,216 −$1.73K
2026-07-14 Allyson G. Krause General Counsel F −20,769 −$8.52K
2026-07-14 Lance I. Solomon Chief Product Officer F −10,670 −$4.37K
2026-07-07 Allyson G. Krause General Counsel A +2,664,077 +$1.01M
2026-07-07 Denise M Merle Director A +394,737 +$150.00K
2026-07-07 Arthur G. Giterman CEO and CFO A +7,092,106 +$2.70M
2026-07-07 Michael B. Strand Chief Revenue Officer A +923,685 +$351.00K
2026-07-07 Robin Mendelson Director A +394,737 +$150.00K
2026-07-07 Lance I. Solomon Chief Product Officer A +1,164,111 +$442.36K
2026-07-07 Lim Kin Simon Leung Director A +592,106 +$225.00K
2026-07-07 Joel A. Getz Director A +394,737 +$150.00K
2026-04-13 Arthur G. Giterman CEO and CFO F −131,150 −$41.97K
2026-04-13 Allyson G. Krause General Counsel F −20,769 −$6.65K
2026-04-13 Michael B. Strand Chief Revenue Officer F −4,216 −$1.35K
2026-04-13 Lance I. Solomon Chief Product Officer F −10,670 −$3.41K
2026-04-13 Ronan O'Loan Chief Human Resources Officer F −7,877 −$2.52K
MYND — Current Insider Holders
InsiderRole Shares HeldValue
Arthur G. Giterman CEO and CFO 8,480,421 $2.92M
Allyson G. Krause General Counsel 3,092,379 $1.07M
Lance I. Solomon Chief Product Officer 1,407,972 $484.91K
Michael B. Strand Chief Revenue Officer 1,050,660 $361.85K
Lim Kin Simon Leung Director 815,010 $280.69K
Denise M Merle Director 539,088 $185.66K
Joel A. Getz Director 539,088 $185.66K
Robin Mendelson Director 539,088 $185.66K
Ronan O'Loan Chief Human Resources Officer 199,071 $68.56K
MYND Insider Trading FAQ
Who are the insiders at MYND?
9 officers, directors and 10%+ beneficial owners currently report holdings in MYND via SEC Form 4.
Are MYND insiders buying or selling?
Across the 21 most recent Form 4 filings for MYND, 0 were open-market purchases (code P) and 0 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is MYND insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent MYND filing is dated 2026-10-13.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the MYND quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.